Outset Medical (OM) Capital Expenditures Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn | -47.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.15% |
| Dec 31, 2025 | 418.60% |
| Sep 30, 2025 | 20.00% |
| Jun 30, 2025 | -118.33% |
| Mar 31, 2025 | -65.25% |
| Dec 31, 2024 | -98.67% |
| Sep 30, 2024 | 4,488.89% |
| Jun 30, 2024 | 120.20% |
| Mar 31, 2024 | -56.30% |
| Dec 31, 2023 | -58.39% |
| Sep 30, 2023 | 99.15% |
| Jun 30, 2023 | -540.00% |
| Mar 31, 2023 | -45.20% |
| Dec 31, 2022 | 463.72% |
| Sep 30, 2022 | -148.82% |
| Jun 30, 2022 | 192.47% |
| Mar 31, 2022 | 521.01% |
| Dec 31, 2021 | -668.35% |
| Sep 30, 2021 | 149.36% |
| Jun 30, 2021 | -103.16% |
| Mar 31, 2021 | -34.97% |
| Dec 31, 2020 | -152.55% |